Kandzari, David E <br/><br/>
TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention.  [electronic resource] 

 -  Current opinion in cardiology  Jul 2002 
 - 332-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0268-4705 
<br/><br/><label>Standard No.: </label>10.1097/00001573-200207000-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Acute Disease<br/>Angina, Unstable--drug therapy<br/>Angioplasty, Balloon, Coronary<br/>Antibodies, Monoclonal--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Coronary Disease--drug therapy<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Myocardial Infarction--drug therapy<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Tirofiban<br/>Tyrosine--analogs & derivatives